Biotransformation of Insecticides

Metabolism of Drugs and Other Xenobiotics

Volumn , Issue , 2012, Pages 685-702

  Ellison, Corie A ^a   Crane, Alice L ^a   Olson, James R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Biotransformation; Carbamate; Insecticide; Metabolism; Organophosphate; Pyrethroid

Indexed keywords

EID: 84876561368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630905.ch25     Document Type: Chapter

References (91)

1. Krieger, R.I. (2010) Hayes' Handbook of Pesticide Toxicology, 3rd edn, Academic Press, San Diego, CA.
2. Knaak, J.B., et al. (2008) Parameters for carbamate pesticide QSAR and PBPK/PD models for human risk assessment. Rev. Environ. Contam. Toxicol., 193, 53-212.
3. Knaak, J.B., et al. (2004) Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment. Crit. Rev. Toxicol., 34, 143-207.
4. Chambers, J.E. and Levi, P.E. (1992) Organophosphates:Chemistry, Fate, and Effects, Academic Press, San Diego, CA.
5. Feldmann, R.J. and Maibach, H.I. (1974) Percutaneous penetration of some pesticides and herbicides in man. Toxicol. Appl. Pharmacol., 28, 126-132.
6. Sams, C., Patel, K., and Jones, K. (2010) Biological monitoring for exposure to pirimicarb:method development and a human oral dosing study. Toxicol. Lett., 192, 56-60.
7. Soderlund, D.M., et al. (2002) Mechanisms of pyrethroid neurotoxicity:implications for cumulative risk assessment. Toxicology, 171, 3-59.
8. Woollen, B.H., et al. (1992) The metabolism of cypermethrin in man:differences in urinary metabolite profiles following oral and dermal administration. Xenobiotica, 22, 983-991.
9. Eadsforth, C.V., Bragt, P.C., and van Sittert, N.J. (1988) Human dose-excretion studies with pyrethroid insecticides cypermethrin and alphacypermethrin:relevance for biological monitoring. Xenobiotica, 18, 603-614.
10. Challis, I.R. and Adcock, J.W. (1981) The metabolism of the carbamate insecticide bendiocarb in the rat and in man. Pestic. Sci., 12, 638-644.
11. Leng, G., Kuhn, K.H., and Idel, H. (1997) Biological monitoring of pyrethroids in blood and pyrethroid metabolites in urine:applications and limitations. Sci. Total Environ., 199, 173-181.
12. Tomalik-Scharte, D., et al. (2005) Dermal absorption of permethrin following topical administration. Eur. J. Clin. Pharmacol., 61, 399-404.
13. Foxenberg, R.J., et al. (2007) Human hepatic cytochrome p450-specific metabolism of parathion and chlorpyrifos. Drug Metab. Dispos., 35, 189-193.
14. Buratti, F.M., et al. (2003) CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicol. Appl. Pharmacol., 186, 143-154.
15. Choi, K., et al. (2006) Metabolism of chlorpyrifos and chlorpyrifos oxon by human hepatocytes. J. Biochem. Mol. Toxicol., 20, 279-291.
16. Poet, T.S., et al. (2003) In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon. Toxicol. Sci., 72, 193-200.
17. Sams, C., Mason, H.J., and Rawbone, R. (2000) Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes. Toxicol. Lett., 116, 217-221.
18. Tang, J., et al. (2001) Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Dispos., 29, 1201-1204.
19. Kim, D.O., et al. (2005) Role of metabolism in parathion-induced hepatotoxicity and immunotoxicity. J. Toxicol. Environ. Health A, 68, 2187-2205.
20. Mutch, E., et al. (2003) Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man? Arch. Toxicol., 77, 313-320.
21. Kappers, W.A., et al. (2001) Diazinon is activated by CYP2C19 in human liver. Toxicol. Appl. Pharmacol., 177, 68-76.
22. Buratti, F.M., et al. (2005) Malathion bioactivation in the human liver:the contribution of different cytochrome p450 isoforms. Drug Metab. Dispos., 33, 295-302.
23. Abass, K., et al. (2007) In vitro metabolism and interaction of profenofos by human, mouse and rat liver preparations. Pestic. Biochem. Physiol., 87, 238-247.
24. Buratti, F.M. and Testai, E. (2007) Evidences for CYP3A4 autoactivation in the desulfuration of dimethoate by the human liver. Toxicology, 241, 33-46.
25. Leoni, C., Buratti, F.M., and Testai, E. (2008) The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol., 233, 343-352.
26. Abass, K., et al. (2009) Metabolism of carbosulfan. I. Species differences in the in vitro biotransformation by mammalian hepatic microsomes including human. Chem. Biol. Interact., 181, 210-219.
27. Abass, K., et al. (2010) Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., 185, 163-173.
28. Tang, J., et al. (2002) In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem. Biol. Interact., 141, 229-241.
29. Usmani, K.A., Hodgson, E., and Rose, R.L. (2004) In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol. Chem. Biol. Interact., 150, 221-232.
30. Anand, S.S., et al. (2006) Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicol. Appl. Pharmacol., 212, 156-166.
31. Godin, S.J., et al. (2007) Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate. Drug Metab. Dispos., 35, 1664-1671.
32. Nakamura, Y., et al. (2007) The in vitro metabolism of a pyrethroid insecticide, permethrin, and its hydrolysis products in rats. Toxicology, 235, 176-184.
33. Ma, T. and Chambers, J.E. (1995) A kinetic analysis of hepatic microsomal activation of parathion and chlorpyrifos in control and phenobarbital-treated rats. J. Biochem. Toxicol., 10, 63-68.
34. Scollon, E.J., et al. (2009) In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms. Drug Metab. Dispos., 37, 221-228.
35. Shimada, T., et al. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals:studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414-423.
36. Yeo, K.R., Rostami-Hodjegan, A., and Tucker, G.T. (2004) Abundance of cytochromes P450 in human liver:a meta-analysis. Br. J. Clin. Pharmacol., 57, 687-688.
37. Usmani, K.A., et al. (2004) In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., 32, 333-339.
38. Tynes, R.E. and Hodgson, E. (1985) Catalytic activity and substrate specificity of the flavin-containing monooxygenase in microsomal systems:characterization of the hepatic, pulmonary and renal enzymes of the mouse, rabbit, and rat. Arch. Biochem. Biophys., 240, 77-93.
39. Phillips, I.R., et al. (1995) The molecular biology of the flavin-containing monooxygenases of man. Chem. Biol. Interact., 96, 17-32.
40. Godin, S.J., et al. (2006) Species differences in the in vitro metabolism of deltamethrin and esfenvalerate:differential oxidative and hydrolytic metabolism by humans and rats. Drug Metab. Dispos., 34, 1764-1771.
41. Ross, M.K., et al. (2006) Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem. Pharmacol., 71, 657-669.
42. Crow, J.A., et al. (2007) Hydrolysis of pyrethroids by human and rat tissues:examination of intestinal, liver and serum carboxylesterases. Toxicol. Appl. Pharmacol., 221, 1-12.
43. Buratti, F.M. and Testai, E. (2005) Malathion detoxification by human hepatic carboxylesterases and its inhibition by isomalathion and other pesticides. J. Biochem. Mol. Toxicol., 19, 406-414.
44. Povey, A.C. (2010) Gene-environmental interactions and organophosphate toxicity. Toxicology, 278, 294-304.
45. Furlong, C.E., et al. (2005) Paraoxonase 1 (PON1) status and risk of insecticide exposure. J. Biochem. Mol. Toxicol., 19, 182-183.
46. Costa, L.G. (2006) Current issues in organophosphate toxicology. Clin. Chim. Acta, 366, 1-13.
47. Davies, H.G., et al. (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet., 14, 334-336.
48. Li, W.F., et al. (2000) Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics, 10, 767-779.
49. Bicker, W., et al. (2005) A case study of acute human chlorpyrifos poisoning:novel aspects on metabolism and toxicokinetics derived from liquid chromatography-tandem mass spectrometry analysis of urine samples. Toxicol. Lett., 159, 235-251.
50. Fujioka, K. and Casida, J.E. (2007) Glutathione S-transferase conjugation of organophosphorus pesticides yields S-phospho-, S-aryl-, and S-alkylglutathione derivatives. Chem. Res. Toxicol., 20, 1211-1217.
51. Ecobichon, D.J. and Joy, R.M. (1994) Pesticides and Neurological Diseases, 2nd edn, CRC Press, Boca Raton, FL.
52. Pena-Llopis, S., Ferrando, M.D., and Pena, J.B. (2003) Fish tolerance to organophosphate-induced oxidative stress is dependent on the glutathione metabolism and enhanced by N-acetylcysteine. Aquat. Toxicol., 65, 337-360.
53. Falcioni, M.L., et al. (2010) The primary role of glutathione against nuclear DNA damage of striatum induced by permethrin in rats. Neuroscience, 168, 2-10.
54. Banerjee, B.D., Seth, V., and Ahmed, R.S. (2001) Pesticide-induced oxidative stress:perspectives and trends. Rev. Environ. Health, 16, 1-40.
55. Paine, M.F., et al. (2006) The human intestinal cytochrome P450 "pie". Drug Metab. Dispos., 34, 880-886.
56. Yeung, C.K., et al. (2000) Immunoquantitation of FMO1 in human liver, kidney, and intestine. Drug Metab. Dispos., 28, 1107-1111.
57. Furnes, B. and Schlenk, D. (2005) Extrahepatic metabolism of carbamate and organophosphate thioether compounds by the flavin-containing monooxygenase and cytochrome P450 systems. Drug Metab. Dispos, 33, 214-218.
58. Baron, J.M. and Skazik, C. (2010) Research in practice:the second barrier of the human skin. J. Dtsch. Dermatol. Ges, 8, 155-158.
59. Venkatesh, K., et al. (1992) The flavin-containing monooxygenase in mouse lung:evidence for expression of multiple forms. J. Biochem. Toxicol., 7, 163-169.
60. Williams, P.L., Carver, M.P., and Riviere, J.E. (1990) A physiologically relevant pharmacokinetic model of xenobiotic percutaneous absorption utilizing the isolated perfused porcine skin flap. J. Pharm. Sci., 79, 305-311.
61. Dahl, A.R. and Gerde, P. (1994) Uptake and metabolism of toxicants in the respiratory tract. Environ. Health Perspect., 102 (Suppl. 11), 67-70.
62. Yadav, S., et al. (2006) Regional specificity in deltamethrin induced cytochrome P450 expression in rat brain. Toxicol. Appl. Pharmacol., 217, 15-24.
63. Soranno, T.M. and Sultatos, L.G. (1992) Biotransformation of the insecticide parathion by mouse brain. Toxicol. Lett., 60, 27-37.
64. Johri, A., et al. (2006) Long lasting effects of prenatal exposure to deltamethrin on cerebral and hepatic cytochrome P450s and behavioral activity in rat offspring. Eur. J. Pharmacol., 544, 58-68.
65. Forsyth, C.S. and Chambers, J.E. (1989) Activation and degradation of the phosphorothionate insecticides parathion and EPN by rat brain. Biochem. Pharmacol., 38, 1597-1603.
66. de Lima, J.S., et al. (1996) Methyl parathion activation by a partially purified rat brain fraction. Toxicol. Lett., 87, 53-60.
67. Chambers, J.E. and Chambers, H.W. (1989) Oxidative desulfuration of chlorpyrifos, chlorpyrifos-methyl, and leptophos by rat brain and liver. J. Biochem. Toxicol., 4, 201-203.
68. Albores, A., et al. (2001) Cytochrome P450 2B (CYP2B)-mediated activation of methyl-parathion in rat brain extracts. Toxicol. Lett., 124, 1-10.
69. Bhagwat, S.V., Boyd, M.R., and Ravindranath, V. (2000) Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria. Biochem. Pharmacol., 59, 573-582.
70. Bieche, I., et al. (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet. Genomics, 17, 731-742.
71. Gervot, L., et al. (1999) Human CYP2B6:expression, inducibility and catalytic activities. Pharmacogenetics, 9, 295-306.
72. Halpert, J., Hammond, D., and Neal, R.A. (1980) Inactivation of purified rat liver cytochrome P-450 during the metabolism of parathion (diethyl p-nitrophenyl phosphorothionate). J. Biol. Chem., 255, 1080-1089.
73. Hodgson, E. and Rose, R.L. (2006) Organophosphorus chemicals:potent inhibitors of the human metabolism of steroid hormones and xenobiotics. Drug Metab. Rev., 38, 149-162.
74. Abass, K., Turpeinen, M., and Pelkonen, O. (2009) An evaluation of the cytochrome P450 inhibition potential of selected pesticides in human hepatic microsomes. J. Environ. Sci. Health B, 44, 553-563.
75. Rose, R.L. and Hodgson, E. (2005) Pesticide metabolism and potential for metabolic interactions. J. Biochem. Mol. Toxicol., 19, 276-277.
76. Das, P.C., et al. (2008) Enzyme induction and cytotoxicity in human hepatocytes by chlorpyrifos and N,N-diethyl-m-toluamide (DEET). Drug Metabol. Drug Interact., 23, 237-260.
77. Boronat, S., et al. (2007) Modulation of aryl hydrocarbon receptor transactivation by carbaryl, a nonconventional ligand. FEBS J., 274, 3327-3339.
78. Miksys, S., et al. (2003) Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology, 45, 122-132.
79. Axelrad, J.C., Howard, C.V., and McLean, W.G. (2002) Interactions between pesticides and components of pesticide formulations in an in vitro neurotoxicity test. Toxicology, 173, 259-268.
80. Hodgson, E. and Philpot, R.M. (1974) Interaction of methylenedioxyphenyl (1,3-benzodioxole) compounds with enzymes and their effects on mammals. Drug Metab. Rev., 3, 231-301.
81. Ryu, D.Y., Levi, P.E., and Hodgson, E. (1995) Regulation of cytochrome P-450 isozymes CYP1A1, CYP1A2 and CYP2B10 by three benzodioxole compounds. Chem. Biol. Interact., 96, 235-247.
82. Dolphin, C.T., et al. (1996) Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. Eur J Biochem, 235, 683-689.
83. Wolbold, R., et al. (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology, 38, 978-988.
84. Adkins, S., et al. (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase:glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet., 52, 598-608.
85. Leviev, I., Negro, F., and James, R.W. (1997) Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler. Thromb. Vasc. Biol., 17, 2935-2939.
86. Garin, M.C., et al. (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest., 99, 62-66.
87. O'Leary, K.A., et al. (2005) Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans:consequences for risk from exposure to diazinon. Pharmacogenet. Genomics, 15, 51-60.
88. Li, W.F., Costa, L.G., and Furlong, C.E. (1993) Serum paraoxonase status:a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health, 40, 337-346.
89. Dai, D., et al. (2001) Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J. Pharmacol. Exp. Ther., 299, 825-831.
90. Shimizu, T., et al. (2003) Bioinformatics research on inter-racial difference in drug metabolism II. Analysis on relationship between enzyme activities of CYP2D6 and CYP2C19 and their relevant genotypes. Drug Metab. Pharmacokinet., 18, 71-78.
91. Bozina, N., Bradamante, V., and Lovric, M. (2009) Genetic polymorphism of metabolic enzymes P450 (Cyp) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh. Hig. Rada Toksikol., 60, 217-242.